Will they absorb lessons learned from Merck’s mistakes? As Glaxo is forced to wait for FDA’s approval for its own HPV vaccine, Cervarix, will the company use its time on the sidelines to absorb lessons learned from Merck’s missteps? There is a building backlash against Merck’s … [Read more...] about Can Glaxo learn from Merck
GlaxoSmithKline
Sen. Grassley (R-IA) Keeps Pharmaceutical Industry, FDA In The Crosshairs
A BIG thank you to the Philadelphia Inquirer... One of the few major media outlets that consistently cover Big Pharma and the FDA… This weekend The Philadelphia Inquirer examined how Sen. Chuck Grassley (R-Iowa) has "found a congressional calling" in "creating uproars that … [Read more...] about Sen. Grassley (R-IA) Keeps Pharmaceutical Industry, FDA In The Crosshairs
Gardasil — When Mercketing Pre-empts Medicine
It is not hard to hear about Gardasil... "In television advertisements, a cast of hip people in their 20s — artists, writers and professionals — describe why they got the shots, in the language of liberation, such as, “I chose to get vaccinated because my dreams don’t include … [Read more...] about Gardasil — When Mercketing Pre-empts Medicine
GlaxoSmithKline responds to FDA on Cervarix
Glaxo plans to submit final Cervarix study data for approval Issued – Monday 30 June 2008, London, UK & Philadelphia, US GlaxoSmithKline today provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of … [Read more...] about GlaxoSmithKline responds to FDA on Cervarix
BBC Reports Glaxo’s Very Profitable HPV Vaccine Contract With UK
The following BBC story diagrams the corporate infighting over which multi-national Pharma Giant wins the very profitable HPV vaccine contract with the UK public health department. Glaxo needed a win big time. Merck has effectively shut them out of the lucrative American market, … [Read more...] about BBC Reports Glaxo’s Very Profitable HPV Vaccine Contract With UK